Lenar Aimee J. sold 36,827 shares of Bausch Health Companies Inc. at $7.03 for −$259k on Aug 19, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
President, US Pharma
President, US Pharma
Filed Aug 20, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$258,893.81Shares × reported price
Shares traded
36,827Common Shares, No Par Value
Price per share
$7.03Reported price. Read footnotes for ranges.
% of reported position traded
9.91%This security and ownership context
Holdings after
334,853Direct
Trade date
Aug 19, 2026Sell
Filed
Aug 20, 2026, 4:33 PM ET1-day reporting delay
Accession
0000885590-26-000109Code S · Transaction 13067
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 371,680 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

BHC price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
BHC · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −31%1w ago −8.8%1d ago +1.8%
Returns since7d −7.5%30d −17%90d180d1y

Footnotes in full

F1: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-l plan adopted by the Reporting Person on May 21, 2026.